OrbiMed Royalty & Credit Opportunities III, LP — Form D/A
OrbiMed Royalty & Credit Opportunities III, LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2019-07-03. The offering totals $1.2B, of which $889.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-07-03
- Form: D/A
- Accession: 0001766289-19-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $1.2B
- Amount sold: $889.8M
- Remaining: $310.2M
- Investors: 69
- Date of first sale: 2019-01-30
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-331673
Issuer
- Name: OrbiMed Royalty & Credit Opportunities III, LP
- CIK: 0001766289
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 601 LEXINGTON AVENUE, NEW YORK, NY, 10022
- Phone: 212-739-6400
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Sven H Borho | Executive Officer | New York, NY |
| Carl L Gordon | Executive Officer | Stamford, CT |
| Geoffrey C Hsu | Executive Officer | New York, NY |
| W. Carter Neild | Executive Officer | NEW YORK, NY |
| N/A NA OrbiMed Advisors LLC | Executive Officer | New York, NY |
| N/A NA OrbiMed ROF III LLC | Executive Officer | New York, NY |
| Jonathan T Silverstein | Executive Officer | New York, NY |
| N/A NA OrbiMed Advisors LLC | Promoter | New York, NY |
Other filings by this issuer (1)
More